共 49 条
Plasma deposited stability enhancement coating for amorphous ketoprofen
被引:10
作者:
Bosselmann, Stephanie
[1
]
Owens, Donald E., III
[2
]
Kennedy, Rachel L.
[2
]
Herpin, Matthew J.
[2
]
Williams, Robert O., III
机构:
[1] Univ Texas Austin, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA
[2] AeonClad Biomed LLC, Austin, TX USA
基金:
美国国家科学基金会;
关键词:
Plasma-enhanced chemical vapor deposition;
Amorphous drug;
Recrystallization;
Physical stability;
Fluorocarbons;
GLASS-TRANSITION TEMPERATURE;
PHARMACEUTICAL DOSAGE FORMS;
WATER-SOLUBLE DRUGS;
SOLID DISPERSIONS;
BIOMEDICAL APPLICATIONS;
BARRIER COATINGS;
FORCE MICROSCOPY;
POLYMERIC FILMS;
THIN-FILMS;
CRYSTALLIZATION;
D O I:
10.1016/j.ejpb.2010.12.011
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
A hydrophobic fluorocarbon coating deposited onto amorphous ketoprofen via pulsed plasma-enhanced chemical vapor deposition (PPECVD) significantly prolonged the onset of recrystallization compared to uncoated drug. Rapid freezing (RF) employed to produce amorphous ketoprofen was followed by PPECVD of perfluorohexane. The effect of coating thickness on the recrystallization and dissolution behavior of ketoprofen was investigated. Samples were stored in open containers at 40 degrees C and 75% relative humidity, and the onset of recrystallization was monitored by DSC. An increase in coating thickness provided enhanced stability against recrystallization for up to 6 months at accelerated storage conditions (longest time of observation) when compared to three days for uncoated ketoprofen. Results from XPS analysis demonstrated that an increase in coating thickness was associated with improved surface coverage thus enabling superior protection. Dissolution testing showed that at least 80% of ketoprofen was released in buffer pH 6.8 from all coated samples. Overall, an increase in coating thickness resulted in a more complete drug release due to decreased adhesion of the coating to the substrate. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文